Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07111988
PHASE2

Valbenazine in Obsessive Compulsive Disorder

Sponsor: University of Chicago

View on ClinicalTrials.gov

Summary

The primary aim of the study is to examine the efficacy and safety of valbenazine in adults with moderate to severe obsessive-compulsive disorder (OCD).

Official title: Valbenazine in Obsessive-compulsive Disorder: A Randomized Double-blind Placebo-controlled Crossover Trial

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2026-02

Completion Date

2027-12

Last Updated

2026-02-05

Healthy Volunteers

No

Interventions

DRUG

Valbenazine

Selective vesicular monoamine transporter 2 (VMAT2) inhibitor

DRUG

Placebo

Pill that contains no medicine